Virus-Specific CD4+ Memory-Phenotype T Cells Are Abundant in Unexposed Adults

Immunity

Volumn 38, Issue 2, 2013, Pages 373-383

  Su, Laura F ^a   Kidd, Brian A ^a   Han, Arnold ^a   Kotzin, Jonathan J ^a   Davis, Mark M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN RECOGNITION; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CROSS REACTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLUENZA VIRUS; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL; VIRUS IMMUNITY;

ADULT; AMINO ACID SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CHILD; CLONE CELLS; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; INFANT, NEWBORN; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MOLECULAR SEQUENCE DATA; PEPTIDES; PHENOTYPE; RECEPTORS, ANTIGEN, T-CELL; T-CELL ANTIGEN RECEPTOR SPECIFICITY; VACCINATION;

EID: 84874253445     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2012.10.021     Document Type: Article

References (52)

1. Aaby P., Jensen H., Samb B., Cisse B., Sodemann M., Jakobsen M., Poulsen A., Rodrigues A., Lisse I.M., Simondon F., Whittle H. Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: reanalysis of West African studies. Lancet 2003, 361:2183-2188.
2. Aaby P., Martins C.L., Garly M.L., Balé C., Andersen A., Rodrigues A., Ravn H., Lisse I.M., Benn C.S., Whittle H.C. Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial. BMJ 2010, 341:c6495.
3. Akue A.D., Lee J.Y., Jameson S.C. Derivation and maintenance of virtual memory CD8 T cells. J. Immunol. 2012, 188:2516-2523.
4. Alexander J., Bilsel P., del Guercio M.F., Stewart S., Marinkovic-Petrovic A., Southwood S., Crimi C., Vang L., Walker L., Ishioka G., et al. Universal influenza DNA vaccine encoding conserved CD4+ T cell epitopes protects against lethal viral challenge in HLA-DR transgenic mice. Vaccine 2010, 28:664-672.
5. Appay V., van Lier R.A., Sallusto F., Roederer M. Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytometry A 2008, 73:975-983.
6. Arif S., Tree T.I., Astill T.P., Tremble J.M., Bishop A.J., Dayan C.M., Roep B.O., Peakman M. Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J. Clin. Invest. 2004, 113:451-463.
7. Auger I., Sebbag M., Vincent C., Balandraud N., Guis S., Nogueira L., Svensson B., Cantagrel A., Serre G., Roudier J. Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrinogen. Arthritis Rheum. 2005, 52:3424-3432.
8. Benoist C., Mathis D. Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry?. Nat. Immunol. 2001, 2:797-801.
9. Bronke C., Palmer N.M., Westerlaken G.H., Toebes M., van Schijndel G.M., Purwaha V., van Meijgaarden K.E., Schumacher T.N., van Baarle D., Tesselaar K., Geluk A. Direct ex vivo detection of HLA-DR3-restricted cytomegalovirus- and Mycobacterium tuberculosis-specific CD4+ T cells. Hum. Immunol. 2005, 66:950-961.
10. Casanova J.L., Abel L. Inborn errors of immunity to infection: the rule rather than the exception. J. Exp. Med. 2005, 202:197-201.
11. Cho J.H., Kim H.O., Surh C.D., Sprent J. T cell receptor-dependent regulation of lipid rafts controls naive CD8+ T cell homeostasis. Immunity 2010, 32:214-226.
12. Chu H.H., Moon J.J., Kruse A.C., Pepper M., Jenkins M.K. Negative selection and peptide chemistry determine the size of naive foreign peptide-MHC class II-specific CD4+ T cell populations. J. Immunol. 2010, 185:4705-4713.
13. Cossarizza A., Ortolani C., Paganelli R., Barbieri D., Monti D., Sansoni P., Fagiolo U., Castellani G., Bersani F., Londei M., Franceschi C. CD45 isoforms expression on CD4+ and CD8+ T cells throughout life, from newborns to centenarians: implications for T cell memory. Mech. Ageing Dev. 1996, 86:173-195.
14. Day C.L., Seth N.P., Lucas M., Appel H., Gauthier L., Lauer G.M., Robbins G.K., Szczepiorkowski Z.M., Casson D.R., Chung R.T., et al. Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers. J. Clin. Invest. 2003, 112:831-842.
15. Decman V., Laidlaw B.J., Doering T.A., Leng J., Ertl H.C., Goldstein D.R., Wherry E.J. Defective CD8 T cell responses in aged mice are due to quantitative and qualitative changes in virus-specific precursors. J. Immunol. 2012, 188:1933-1941.
16. den Braber I., Mugwagwa T., Vrisekoop N., Westera L., Mögling R., de Boer A.B., Willems N., Schrijver E.H., Spierenburg G., Gaiser K., et al. Maintenance of peripheral naive T cells is sustained by thymus output in mice but not humans. Immunity 2012, 36:288-297.
17. Diethelm-Okita B.M., Raju R., Okita D.K., Conti-Fine B.M. Epitope repertoire of human CD4+ T cells on tetanus toxin: identification of immunodominant sequence segments. J. Infect. Dis. 1997, 175:382-391.
18. Flynn K.J., Belz G.T., Altman J.D., Ahmed R., Woodland D.L., Doherty P.C. Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity 1998, 8:683-691.
19. Guimond M., Veenstra R.G., Grindler D.J., Zhang H., Cui Y., Murphy R.D., Kim S.Y., Na R., Hennighausen L., Kurtulus S., et al. Interleukin 7 signaling in dendritic cells regulates the homeostatic proliferation and niche size of CD4+ T cells. Nat. Immunol. 2009, 10:149-157.
20. Haining W.N., Angelosanto J., Brosnahan K., Ross K., Hahn C., Russell K., Drury L., Norton S., Nadler L., Stegmaier K. High-throughput gene expression profiling of memory differentiation in primary human T cells. BMC Immunol. 2008, 9:44.
21. Haluszczak C., Akue A.D., Hamilton S.E., Johnson L.D., Pujanauski L., Teodorovic L., Jameson S.C., Kedl R.M. The antigen-specific CD8+ T cell repertoire in unimmunized mice includes memory phenotype cells bearing markers of homeostatic expansion. J. Exp. Med. 2009, 206:435-448.
22. Hammer J., Belunis C., Bolin D., Papadopoulos J., Walsky R., Higelin J., Danho W., Sinigaglia F., Nagy Z.A. High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations. Proc. Natl. Acad. Sci. USA 1994, 91:4456-4460.
23. Jameson S.C., Masopust D. Diversity in T cell memory: an embarrassment of riches. Immunity 2009, 31:859-871.
24. Johnston V.J., Mabey D.C. Global epidemiology and control of Trichomonas vaginalis. Curr. Opin. Infect. Dis. 2008, 21:56-64.
25. Kristensen I., Aaby P., Jensen H. Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa. BMJ 2000, 321:1435-1438.
26. Kwok W.W., Tan V., Gillette L., Littell C.T., Soltis M.A., LaFond R.B., Yang J., James E.A., DeLong J.H. Frequency of epitope-specific naive CD4(+) T cells correlates with immunodominance in the human memory repertoire. J. Immunol. 2012, 188:2537-2544.
27. Lackritz E.M., Satten G.A., Aberle-Grasse J., Dodd R.Y., Raimondi V.P., Janssen R.S., Lewis W.F., Notari E.P., Petersen L.R. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N. Engl. J. Med. 1995, 333:1721-1725.
28. Lamb J.R., Eckels D.D., Lake P., Woody J.N., Green N. Human T-cell clones recognize chemically synthesized peptides of influenza haemagglutinin. Nature 1982, 300:66-69.
29. Levy P.Y., Fenollar F., Stein A., Borrione F., Raoult D. Finegoldia magna: a forgotten pathogen in prosthetic joint infection rediscovered by molecular biology. Clin. Infect. Dis. 2009, 49:1244-1247.
30. Mascher B., Schlenke P., Seyfarth M. Expression and kinetics of cytokines determined by intracellular staining using flow cytometry. J. Immunol. Methods 1999, 223:115-121.
31. Min B., Foucras G., Meier-Schellersheim M., Paul W.E. Spontaneous proliferation, a response of naive CD4 T cells determined by the diversity of the memory cell repertoire. Proc. Natl. Acad. Sci. USA 2004, 101:3874-3879.
32. Moon J.J., Chu H.H., Pepper M., McSorley S.J., Jameson S.C., Kedl R.M., Jenkins M.K. Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 2007, 27:203-213.
33. Moore S.E., Cole T.J., Collinson A.C., Poskitt E.M., McGregor I.A., Prentice A.M. Prenatal or early postnatal events predict infectious deaths in young adulthood in rural Africa. Int. J. Epidemiol. 1999, 28:1088-1095.
34. Newell E.W., Ely L.K., Kruse A.C., Reay P.A., Rodriguez S.N., Lin A.E., Kuhns M.S., Garcia K.C., Davis M.M. Structural basis of specificity and cross-reactivity in T cell receptors specific for cytochrome c-I-E(k). J. Immunol. 2011, 186:5823-5832.
35. Nielen M.M., van der Horst A.R., van Schaardenburg D., van der Horst-Bruinsma I.E., van de Stadt R.J., Aarden L., Dijkmans B.A., Hamann D. Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis. Ann. Rheum. Dis. 2005, 64:1199-1204.
36. Norris P.J., Moffett H.F., Brander C., Allen T.M., O'Sullivan K.M., Cosimi L.A., Kaufmann D.E., Walker B.D., Rosenberg E.S. Fine specificity and cross-clade reactivity of HIV type 1 Gag-specific CD4+ T cells. AIDS Res. Hum. Retroviruses 2004, 20:315-325.
37. Novak E.J., Liu A.W., Gebe J.A., Falk B.A., Nepom G.T., Koelle D.M., Kwok W.W. Tetramer-guided epitope mapping: rapid identification and characterization of immunodominant CD4+ T cell epitopes from complex antigens. J. Immunol. 2001, 166:6665-6670.
38. Obar J.J., Khanna K.M., Lefrançois L. Endogenous naive CD8+ T cell precursor frequency regulates primary and memory responses to infection. Immunity 2008, 28:859-869.
39. Phan G.Q., Touloukian C.E., Yang J.C., Restifo N.P., Sherry R.M., Hwu P., Topalian S.L., Schwartzentruber D.J., Seipp C.A., Freezer L.J., et al. Immunization of patients with metastatic melanoma using both class I- and class II-restricted peptides from melanoma-associated antigens. J. Immunother. 2003, 26:349-356.
40. Reinherz E.L., Tan K., Tang L., Kern P., Liu J., Xiong Y., Hussey R.E., Smolyar A., Hare B., Zhang R., et al. The crystal structure of a T cell receptor in complex with peptide and MHC class II. Science 1999, 286:1913-1921.
41. Reiser J.B., Darnault C., Grégoire C., Mosser T., Mazza G., Kearney A., van der Merwe P.A., Fontecilla-Camps J.C., Housset D., Malissen B. CDR3 loop flexibility contributes to the degeneracy of TCR recognition. Nat. Immunol. 2003, 4:241-247.
42. Rudd B.D., Venturi V., Li G., Samadder P., Ertelt J.M., Way S.S., Davenport M.P., Nikolich-Žugich J. Nonrandom attrition of the naive CD8+ T-cell pool with aging governed by T-cell receptor:pMHC interactions. Proc. Natl. Acad. Sci. USA 2011, 108:13694-13699.
43. Sette A., Sidney J., Oseroff C., del Guercio M.F., Southwood S., Arrhenius T., Powell M.F., Colón S.M., Gaeta F.C., Grey H.M. HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions. J. Immunol. 1993, 151:3163-3170.
44. Shann F., Nohynek H., Scott J.A., Hesseling A., Flanagan K.L. Randomized trials to study the nonspecific effects of vaccines in children in low-income countries. Pediatr. Infect. Dis. J. 2010, 29:457-461. Working Group on Nonspecific Effects of Vaccines.
45. Southwood S., Sidney J., Kondo A., del Guercio M.F., Appella E., Hoffman S., Kubo R.T., Chesnut R.W., Grey H.M., Sette A. Several common HLA-DR types share largely overlapping peptide binding repertoires. J. Immunol. 1998, 160:3363-3373.
46. Sprent J., Surh C.D. Normal T cell homeostasis: the conversion of naive cells into memory-phenotype cells. Nat. Immunol. 2011, 12:478-484.
47. Veirum J.E., Sodemann M., Biai S., Jakobsen M., Garly M.L., Hedegaard K., Jensen H., Aaby P. Routine vaccinations associated with divergent effects on female and male mortality at the paediatric ward in Bissau, Guinea-Bissau. Vaccine 2005, 23:1197-1204.
48. Welsh R.M., Che J.W., Brehm M.A., Selin L.K. Heterologous immunity between viruses. Immunol. Rev. 2010, 235:244-266.
49. Weng N.P., Araki Y., Subedi K. The molecular basis of the memory T cell response: differential gene expression and its epigenetic regulation. Nat. Rev. Immunol. 2012, 12:306-315.
50. Yuan J., Ku G.Y., Gallardo H.F., Orlandi F., Manukian G., Rasalan T.S., Xu Y., Li H., Vyas S., Mu Z., et al. Safety and immunogenicity of a human and mouse gp100 DNA vaccine in a phase I trial of patients with melanoma. Cancer Immun. 2009, 9:5.
51. Zavala-Ruiz Z., Strug I., Walker B.D., Norris P.J., Stern L.J. A hairpin turn in a class II MHC-bound peptide orients residues outside the binding groove for T cell recognition. Proc. Natl. Acad. Sci. USA 2004, 101:13279-13284.
52. Zhang L., Nakayama M., Eisenbarth G.S. Insulin as an autoantigen in NOD/human diabetes. Curr. Opin. Immunol. 2008, 20:111-118.